Both CD8+ T cells and NK cells were found to be the primary producers of IFNγ in both WT and IFNγRKO tumours during earlier stages of tumour development (i.e. days 7–8 post-engraftment) (Fig. 6D, E). Here, CD8A is linked to neoplasm.